amylase 24600 UNT / lipase 4200 UNT / protease 14200 UNT Delayed Release Oral Capsule [Pancreaze]
RxNorm concept 1806966, branded drug (sbd). Prescribable name: PANCREAZE 4200 UNT / 24,600 UNT / 14,200 UNT Delayed Release Oral Capsule.
- RxCUI
- 1806966
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1806966 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Pancreaze (amylase 24,600 UNT / lipase 4200 UNT / protease 14,200 UNT) Delayed Release Oral Capsule; Pancreaze (amylases 24,600 UNT / endopeptidases 14,200 UNT / lipase 4200 UNT) Delayed Release Oral Capsule
Related concepts
- lipase 4200 UNT (SCDC, consists of)
- amylase 24600 UNT (SCDC, consists of)
- protease 14200 UNT (SCDC, consists of)
- amylase 24600 UNT / lipase 4200 UNT / protease 14200 UNT [Pancreaze] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Pancreaze (BN, has ingredient)
- amylase 24600 UNT / lipase 4200 UNT / protease 14200 UNT Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1806966 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1806966 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1806966. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.